Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.53 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.53 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | BRAF | P15056 | 1/20 | 0.49 |
| ▸ | ERN1 | O75460 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | GRM5 | P41594 | 2/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.47 |
| ▸ | GAK | O14976 | 1/20 | 0.46 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.46 |
| ▸ | COQ8A | Q8NI60 | 1/20 | 0.46 |
| ▸ | NLK | Q9UBE8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29096082 | 1.00 | SYK (0.57) | SYKKDM4EMAPTPDGFRBPDGFRA | |
| SCHEMBL27797044 | 0.98 | SYK (0.56) | SYKKDM4EMAPTPDGFRBPDGFRA | |
| SCHEMBL828159 | 0.85 | GAK (0.55) | SYKSMN1; SMN2BRAFLMNAGAK | |
| SCHEMBL17980734 | 0.84 | ALDH1A1 (0.55) | SYKMAPTPDGFRABRAFALDH1A1 | |
| SCHEMBL4705708 | 0.83 | KDM4E (0.45) | SYKKDM4EMAPTFABP5SMN1; SMN2 | |
| Iodide SCHEMBL14236731 | 0.83 | GAK (0.54) | SYKSMN1; SMN2BRAFLMNAGAK | |
| Iodide SCHEMBL14236729 | 0.83 | GAK (0.54) | SYKSMN1; SMN2BRAFLMNAGAK | |
| SCHEMBL28178369 | 0.83 | MAPT (0.54) | SYKKDM4EMAPTFABP5ALDH1A1 | |
| SCHEMBL7482222 | 0.83 | EGFR (0.60) | PDGFRBPDGFRA | |
| SCHEMBL9601934 | 0.82 | SYK (0.54) | SYKKDM4EMAPTSMN1; SMN2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116943730-B | Method for preparing cyclic amine compound by catalyzing hydrogenation of pyridine and quinoline compound | 浙江大学 | 2025-04-11 | — | — | CN | claimed |
| CN-118243829-B | Method for detecting effective components of montmorillonite medicament for treating diarrhea | 南通大学附属医院 | 2024-08-30 | — | — | CN | claimed |
| CN-118243829-A | Method for detecting effective components of montmorillonite medicament for treating diarrhea | 南通大学附属医院 | 2024-06-25 | — | — | CN | claimed |
| CN-117160451-A | Platinum-tin bimetallic catalyst for quinoline compound reduction methylation and preparation method and application thereof | 浙江大学衢州研究院 | 2023-12-05 | — | — | CN | claimed |
| CN-116943730-A | Method for preparing cyclic amine compound by catalyzing hydrogenation of pyridine and quinoline compound | 浙江大学 | 2023-10-27 | — | — | CN | claimed |
| CN-114105984-B | Method for preparing indolizine type corrosion inhibitor | 中国石油大学(华东) | 2023-08-25 | — | — | CN | claimed |
| CN-114105984-A | Preparation method of indolizine corrosion inhibitor | 中国石油大学(华东) | 2022-03-01 | — | — | CN | claimed |
| CN-105753838-A | Novel high-regioselectivity amination method of quinoline derivatives | 安阳师范学院 | 2016-07-13 | — | — | CN | claimed |
| US-20260062393-A1 | Compounds | CTXT PTY LTD (AU) | 2026-03-05 | — | — | US | disclosed |
| US-12365655-B2 | Compounds | CTXT PTY LTD (AU) | 2025-07-22 | — | — | US | disclosed |
| CN-112334466-B | Compounds of formula (I) | CTXT私人有限公司 | 2025-05-30 | — | — | CN | disclosed |
| US-20250129016-A1 | PHOTOREDOX METHODS FOR RADIOCYANATION OF ARENES AND USE THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2025-04-24 | — | — | US | disclosed |
| CN-116943730-B | Method for preparing cyclic amine compound by catalyzing hydrogenation of pyridine and quinoline compound | 浙江大学 | 2025-04-11 | — | — | CN | disclosed |
| CN-119462501-A | Preparation method of 2-quinolinamide compound promoted by acidic ionic liquid | 内蒙古民族大学 | 2025-02-18 | — | — | CN | disclosed |
| EP-1268412-A1 | SULPHONAMIDO-SUBSTITUTED BRIDGED BICYCLOALKYL DERIVATIVES | MERCK SHARP & DOHME LTD. (GB) | 2003-01-02 | — | — | EP | disclosed |
| WO-2002036555-A1 | SULFAMIDES AS GAMMA-SECRETASE INHIBITORS | MERCK SHARP & DOHME LIMITED (GB) | 2002-05-10 | — | — | WO | disclosed |
| WO-2001070677-A1 | SULPHONAMIDO-SUBSTITUTED BRIDGED BICYCLOALKYL DERIVATIVES | MERCK SHARP & DOHME LIMITED (GB) | 2001-09-27 | — | — | WO | disclosed |
| EP-0240859-B1 | LIPOXYGENASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 1993-04-28 | — | — | EP | disclosed |
| US-3988155-A | CYANINE SENSITIZING DYES | FUJI PHOTO FILM CO., LTD. (JA) | 1976-10-26 | — | — | US | disclosed |
| US-3985563-A | Silver halide photographic emulsion | FUJI PHOTO FILM CO., LTD. (JA) | 1976-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062393-A1 | Compounds | SCN2B, ABCB11, SCN1B | SYK 2258/4885KDM4E 800/4885MAPT 2629/4885 |
| US-20250129016-A1 | PHOTOREDOX METHODS FOR RADIOCYANATION OF ARENES AND USE THEREOF | RCC2, PPOX, FTO | SYK 3237/4885KDM4E 290/4885MAPT 2387/4885 |
| US-12365655-B2 | Compounds | SLC10A1, ABCB11, PCSK9 | SYK 1807/4885KDM4E 4009/4885MAPT 1136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.